<DOC>
	<DOCNO>NCT00726427</DOCNO>
	<brief_summary>The purpose study assess safety tolerability AZD1656 single ascend oral dos healthy male subject</brief_summary>
	<brief_title>A Study Evaluate Safety Tolerability After Oral Dosing AZD1656 Healthy Volunteers</brief_title>
	<detailed_description />
	<criteria>Provision inform consent Clinically normal physical finding laboratory value judge investigator include negative test Hepatitis B surface antigen , antibody HIV virus antibody hepatitis C virus . Clinically significant illness clinically relevant trauma , judge investigator , within 2 week first administration Investigational Product History psychiatric somatic disease/condition may interfere objective study , judge investigator</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>December 2010</verification_date>
	<keyword>pharmacokinetics</keyword>
	<keyword>pharmacodynamics</keyword>
	<keyword>AZD1656</keyword>
	<keyword>safety</keyword>
	<keyword>tolerability</keyword>
	<keyword>Healthy Volunteers</keyword>
</DOC>